Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.

PURPOSE: The increasing incidence of small renal tumors in an aging population with comorbidities has stimulated the development of minimally invasive treatments. This study aimed to assess the efficacy and demonstrate feasibility of multimodality imaging of intratumoral administration of holmium-16...

Full description

Bibliographic Details
Main Authors: Wouter Bult, Stephanie G C Kroeze, Mattijs Elschot, Peter R Seevinck, Freek J Beekman, Hugo W A M de Jong, Donald R A Uges, Jos G W Kosterink, Peter R Luijten, Wim E Hennink, Alfred D van het Schip, J L H Ruud Bosch, J Frank W Nijsen, Judith J M Jans
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3540022?pdf=render
_version_ 1828468096773390336
author Wouter Bult
Stephanie G C Kroeze
Mattijs Elschot
Peter R Seevinck
Freek J Beekman
Hugo W A M de Jong
Donald R A Uges
Jos G W Kosterink
Peter R Luijten
Wim E Hennink
Alfred D van het Schip
J L H Ruud Bosch
J Frank W Nijsen
Judith J M Jans
author_facet Wouter Bult
Stephanie G C Kroeze
Mattijs Elschot
Peter R Seevinck
Freek J Beekman
Hugo W A M de Jong
Donald R A Uges
Jos G W Kosterink
Peter R Luijten
Wim E Hennink
Alfred D van het Schip
J L H Ruud Bosch
J Frank W Nijsen
Judith J M Jans
author_sort Wouter Bult
collection DOAJ
description PURPOSE: The increasing incidence of small renal tumors in an aging population with comorbidities has stimulated the development of minimally invasive treatments. This study aimed to assess the efficacy and demonstrate feasibility of multimodality imaging of intratumoral administration of holmium-166 microspheres ((166)HoAcAcMS). This new technique locally ablates renal tumors through high-energy beta particles, while the gamma rays allow for nuclear imaging and the paramagnetism of holmium allows for MRI. METHODS: (166)HoAcAcMS were administered intratumorally in orthotopic renal tumors (Balb/C mice). Post administration CT, SPECT and MRI was performed. At several time points (2 h, 1, 2, 3, 7 and 14 days) after MS administration, tumors were measured and histologically analyzed. Holmium accumulation in organs was measured using inductively coupled plasma mass spectrometry. RESULTS: (166)HoAcAcMS were successfully administered to tumor bearing mice. A striking near-complete tumor-control was observed in (166)HoAcAcMS treated mice (0.10±0.01 cm(3) vs. 4.15±0.3 cm(3) for control tumors). Focal necrosis and inflammation was present from 24 h following treatment. Renal parenchyma outside the radiated region showed no histological alterations. Post administration CT, MRI and SPECT imaging revealed clear deposits of (166)HoAcAcMS in the kidney. CONCLUSIONS: Intratumorally administered (166)HoAcAcMS has great potential as a new local treatment of renal tumors for surgically unfit patients. In addition to strong cancer control, it provides powerful multimodality imaging opportunities.
first_indexed 2024-12-11T04:16:48Z
format Article
id doaj.art-e2b53416b57e4933b35e1397e994d9aa
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T04:16:48Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e2b53416b57e4933b35e1397e994d9aa2022-12-22T01:21:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5217810.1371/journal.pone.0052178Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.Wouter BultStephanie G C KroezeMattijs ElschotPeter R SeevinckFreek J BeekmanHugo W A M de JongDonald R A UgesJos G W KosterinkPeter R LuijtenWim E HenninkAlfred D van het SchipJ L H Ruud BoschJ Frank W NijsenJudith J M JansPURPOSE: The increasing incidence of small renal tumors in an aging population with comorbidities has stimulated the development of minimally invasive treatments. This study aimed to assess the efficacy and demonstrate feasibility of multimodality imaging of intratumoral administration of holmium-166 microspheres ((166)HoAcAcMS). This new technique locally ablates renal tumors through high-energy beta particles, while the gamma rays allow for nuclear imaging and the paramagnetism of holmium allows for MRI. METHODS: (166)HoAcAcMS were administered intratumorally in orthotopic renal tumors (Balb/C mice). Post administration CT, SPECT and MRI was performed. At several time points (2 h, 1, 2, 3, 7 and 14 days) after MS administration, tumors were measured and histologically analyzed. Holmium accumulation in organs was measured using inductively coupled plasma mass spectrometry. RESULTS: (166)HoAcAcMS were successfully administered to tumor bearing mice. A striking near-complete tumor-control was observed in (166)HoAcAcMS treated mice (0.10±0.01 cm(3) vs. 4.15±0.3 cm(3) for control tumors). Focal necrosis and inflammation was present from 24 h following treatment. Renal parenchyma outside the radiated region showed no histological alterations. Post administration CT, MRI and SPECT imaging revealed clear deposits of (166)HoAcAcMS in the kidney. CONCLUSIONS: Intratumorally administered (166)HoAcAcMS has great potential as a new local treatment of renal tumors for surgically unfit patients. In addition to strong cancer control, it provides powerful multimodality imaging opportunities.http://europepmc.org/articles/PMC3540022?pdf=render
spellingShingle Wouter Bult
Stephanie G C Kroeze
Mattijs Elschot
Peter R Seevinck
Freek J Beekman
Hugo W A M de Jong
Donald R A Uges
Jos G W Kosterink
Peter R Luijten
Wim E Hennink
Alfred D van het Schip
J L H Ruud Bosch
J Frank W Nijsen
Judith J M Jans
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
PLoS ONE
title Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
title_full Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
title_fullStr Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
title_full_unstemmed Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
title_short Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
title_sort intratumoral administration of holmium 166 acetylacetonate microspheres antitumor efficacy and feasibility of multimodality imaging in renal cancer
url http://europepmc.org/articles/PMC3540022?pdf=render
work_keys_str_mv AT wouterbult intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT stephaniegckroeze intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT mattijselschot intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT peterrseevinck intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT freekjbeekman intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT hugowamdejong intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT donaldrauges intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT josgwkosterink intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT peterrluijten intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT wimehennink intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT alfreddvanhetschip intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT jlhruudbosch intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT jfrankwnijsen intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer
AT judithjmjans intratumoraladministrationofholmium166acetylacetonatemicrospheresantitumorefficacyandfeasibilityofmultimodalityimaginginrenalcancer